http://web.archive.org/web/20140223082625id_/http://www.cnn.com:80/2013/04/17/health/fda-oxycontin

-- in an effort to curb prescription painkiller abuse , the @entity1 is banning generic versions of the original @entity6 formula			1
" the @entity1 has determined that the benefits of original @entity6 no longer outweigh its risks , " the agency said in a statement			1
@entity6 was first approved in 1995			2
the drug became attractive to abusers who crushed it to snort , or melted and injected it			1
oxycontin tablets have a time - release formula that delivers the drug over a 12 - hour period			2
but when a pill is crushed , the entire dose is immediately absorbed into the bloodstream			0
@entity23 , the producer of @entity6 , stopped selling the original formula to pharmacies in august 2010 after reformulating the pills to make them crush - resistant			1
the reformulated pills make the drug more difficult to inject or snort , according to the @entity1			1
the agency has approved new labeling for the drug that makes it clear the pills are more difficult to abuse			1
any generic version of @entity6 that is submitted for approval should be based on this formula , the @entity1 says			1
prescription painkillers have killed more americans than heroin and cocaine combined , according to the @entity41			0
approximately 12 million @entity38 over the age of 12 reported using prescription painkillers recreationally in 2010			0
according to the @entity41 , enough were prescribed that year to medicate every @entity38 adult around the clock for a month			0
deaths have skyrocketed during the past decade			0
in 2009 , about a half a million people visited emergency rooms as a result of abusing or misusing prescription drugs like @entity52 ( hydrocodone ) , @entity6 ( oxycodone ) , @entity55 ( oxymorphone ) and methadone , the @entity41 found			2
in may 2007 , @entity23 settled a lawsuit that alleged the company used promotional materials that contained misleading or inaccurate data and downplayed the addiction risks of @entity6 , according to @entity63			1
the company paid a $ 600.5 million fine and three of the company 's top executives pleaded guilty to a misdemeanor count of misbranding			0
in december , the @entity71 sent an alert to law enforcement , particularly along the @entity75 border , warning that @entity75 had approved non-abuse - resistant generic versions of oxycodone , the active ingredient in @entity6 , @entity79 and about 40 other painkillers			1
" @entity71 expects companies will begin offering these generics without the abuse - resistant features in @entity75 pharmacies within the next month , " according to the alert			0
the letter warned of the potential for these generics to show up in the @entity38			0
going forward , the @entity1 will continue " to encourage the development of abuse - deterrent formulations of opioids , " the agency said			2
" ( we believe ) that such products will help reduce prescription drug abuse			2
at the same time , the @entity1 remains committed to ensuring that patients with pain have appropriate access to opioid analgesics			0
" @entity0 's @entity101 contributed to this report .			0

" the benefits of original @entity6 no longer outweigh its risks , " @entity1 says
the drug is attractive to abusers who crush it to snort , or melt and inject it
reformulated pills from @entity23 make the drug more difficult to abuse
any generic version *seeking* approval should be based on the new formula , @entity1 says

@entity23:Purdue Pharma
@entity1:FDA
@entity0:CNN
@entity6:OxyContin
@entity52:Vicodin
@entity38:United States
@entity101:Saundra Young
@entity79:Percocet
@entity41:CDC
@entity55:Opana
@entity75:Canadian
@entity71:ONDCP
@entity63:Fortune